English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

4. Allen AC, Bailey EM, Brenchley PE et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 2001; 60: 969–973 5. Hiki Y, Odani H, Takahashi M et al. Mass spectrometry proves underO-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 2001; 59: 1077–1085 6. Novak J, Julian BA, Tomana M et al. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin Nephrol 2008; 28: 78–87 7. Barratt J, Smith AC, Molyneux K et al. Immunopathogenesis of IgAN. Semin Immunopathol 2007; 29: 427–443 8. Kokubo T, Hiki Y, Iwase H et al. Evidence for involvement of IgA1 hinge glycopeptide in the IgA1-IgA1 interaction in IgA nephropathy. J Am Soc Nephrol 1997; 8: 915–919 9. Coppo R, Amore A, Gianoglio B et al. Serum IgA and macromolecular IgA reacting with mesangial matrix components. Contrib Nephrol 1993; 104: 162–171 10. Novak J, Tomana M, Matousovic K et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 2005; 67: 504–513 11. Roos A, Bouwman LH, van Gijlswijk-Janssen DJ et al. Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 2001; 167: 2861–2868 12. Xu LX, Yan Y, Zhang JJ et al. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy. Clin Exp Immunol 2005; 142: 569–575 13. Gharavi AG, Moldoveanu Z, Wyatt RJ et al. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 2008; 19: 1008–1014 14. Barratt J, Bailey EM, Buck KS et al. Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy. Am J Kidney Dis 1999; 33: 1049–1057 15. Smith AC, Molyneux K, Feehally J et al. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J Am Soc Nephrol 2006; 17: 3520– 3528 16. Harper SJ, Allen AC, Bene MC et al. Increased dimeric IgA-producing B cells in tonsils in IgA nephropathy determined by in situ hybridization for J chain mRNA. Clin Exp Immunol 1995; 101: 442– 448 17. Harper SJ, Pringle JH, Wicks AC et al. Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy. Kidney Int 1994; 45: 836–844 18. Batra A, Smith AC, Feehally J et al. T-cell homing receptor expression in IgA nephropathy. Nephrol Dial Transplant 2007; 22: 2540– 2548 19. Buren M, Yamashita M, Suzuki Y et al. Altered expression of lymphocyte homing chemokines in the pathogenesis of IgA nephropathy. Contrib Nephrol 2007; 157: 50–55 20. Feehally J, Beattie TJ, Brenchley PE et al. Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int 1986; 30: 924– 931

Rapamycin enhances lifespan: At last, an advantage for transplant recipients?